Agios Pharmaceuticals, Inc. (AGIO)
35.11
+0.31
(+0.89%)
USD |
NASDAQ |
Apr 07, 16:00
35.07
-0.04
(-0.11%)
After-Hours: 07:20
Agios Pharmaceuticals Cash from Investing (TTM) : 377.18M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| Biogen, Inc. | -1.371B |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Apellis Pharmaceuticals, Inc. | -0.313M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |